On July 26, 2022, Curt A. Herberts III, the Chief Operating Officer of Senti Biosciences, Inc., a Delaware corporation (the Company), notified the Company of his decision to resign from his employment with the Company, effective as of August 19, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.2464 USD | -6.38% | -12.19% | -62.67% |
17/05 | Senti Biosciences, Inc. Announces Executive Changes | CI |
09/05 | Senti Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
1st Jan change | Capi. | |
---|---|---|
-62.67% | 11.27M | |
+18.15% | 124B | |
+18.02% | 112B | |
+5.07% | 22.94B | |
-12.75% | 22.22B | |
-9.86% | 17.02B | |
-14.97% | 16.88B | |
-39.94% | 16.87B | |
+2.80% | 13.63B | |
+27.39% | 11.61B |
- Stock Market
- Equities
- SNTI Stock
- News Senti Biosciences, Inc.
- Senti Biosciences, Inc. Announces Resignation of Curt A. Herberts III, Chief Operating Officer Effective as of August 19, 2022